Risk classification for long-term mortality among patients with acute heart failure: China PEACE 4YMortality

Wei Wang1,2, Lihua Zhang1, Guangda He1

  • 1National Clinical Research Center for Cardiovascular Diseases, NHC Key Laboratory of Clinical Research for Cardiovascular Medications, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.

ESC Heart Failure
|March 17, 2025
PubMed

Insights

A new risk prediction model was developed to identify patients hospitalized with acute heart failure (AHF) at high risk of long-term mortality. This tool aids in stratifying risk for improved patient outcomes in China.

Area of Science:

  • Cardiology
  • Public Health
  • Medical Informatics

Background:

  • Limited tools exist for predicting long-term mortality in Chinese patients hospitalized with acute heart failure (AHF).
  • Accurate risk stratification is crucial for managing AHF patients post-discharge.

Purpose of the Study:

  • To develop and validate a predictive model for 4-year mortality risk in patients discharged alive after AHF hospitalization.
  • To establish a practical risk score for clinical use.

Main Methods:

  • Utilized data from the China Patient-Centred Evaluative Assessment of Cardiac Events Prospective Heart Failure Study.
  • Employed a multivariate Cox proportional hazard model for prediction model development and internal validation.
  • Selected 13 predictors including clinical data and biomarkers.

Main Results:

  • The study included 4875 AHF patients; 42.38% died within 4 years.
  • The developed model demonstrated good predictive performance (C-index 0.726 in development, 0.727 in validation).
  • A point-based risk score stratified patients into low, intermediate, and high-risk groups.

Conclusions:

  • A validated risk prediction model using accessible predictors for 4-year mortality in AHF patients was successfully developed.
  • The model is beneficial for individual risk stratification and improving patient outcomes.
  • This tool supports clinical decision-making for AHF survivors.
Abstract